[1] Xiong Zhengwen,Qu Yanjing,Huang Yong,et al.intestinal specimens of light wave-microwave combination technique in paraffin section and immunohistochemical staining in intestinal tract biopsy［J］.Defense of North China Pharmaceuticals,2006,18（5):312-314.［熊正文，曲延静，黄勇，等.光波-微波组合技术在肠道标本石蜡切片与免疫组化染色中的应用［J］.华北国防医药，2006，18(5)：312-314.］
[2] Mathew J,Hines JE,Obafunwa JO,et al.CD44 is expressed in hepato cellular carcinomas showing vascular invasion［J］.J Pathol,1996,179(1):74-79.
[3] Zhang Yigang,Ruan Lixia.pAkt expression in colorectal carcinoma and Ki-67 ［J］.Clin Focus,2014,2（29):181-185.［章亿刚，阮丽霞． Ki-67 和pAkt 在结直肠癌组织中的表达［J］．临床荟萃，2014，2(29):181-185．］
[4] Ye B,Jiang LL,Xu HT,et al.Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis［J］.Int J Immunopathol Pharmacol,2012,25(3):627-636.
[5]Chen X,Liao J,Lu Y,et al.Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1［J］.Pathol Oncol Res,2011,17(2):257－261.
[6]Kang MH,Kim JS,Seo JE,et al.BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of thephos- phatidylinositol 3-kinase(PI3K)/Akt pathway［J］.Exp Cell Res,2010,316(1):24-37．
[7] Malinowsky K，Nitsche U，Janssen KP，et al． Activation of the PI3K/AKT pathway correlates with prognosis in stage Ⅱ colon cancer［J］． Br J Cancer，2014，110(8):2081-2089．
[8]Zou Shaojing,Chen Zhaofeng,Li Min,et al.PI3K/AKT2 expression in gastric cancer and its relationship with clinical pathological characteristics and lifetime［J］.Prac J Cancer,2011,26（4):346-350.［邹绍静，陈兆峰，李敏，等.PI3K/AKT2在胃癌组织表达及其与临床病理特征和生存期的关系［J］.实用肿瘤杂志，2011，26(4)：346-350.］
[9] Huang J，Che MI，Lin NY，et al． The molecular chaperone cosmcenhances malignant behaviors of colon cancer cells via activation of Akt and EＲK［J］． Mol Carcinog，2014，53(Suppl 1):E62-71．
[10] Allen JE，Gallant JN，Dicker DT，et al．The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer［J］．PLoS One，2013，8(3):e59380．
[11]Bhutani J，Sheikh A，Niazi AK，et al．Akt inhibitors:Mechanism of action and implications for anticancer therapeutics［J］． Infect Agent Cancer，2013，8(1):49．
[12]Kang S,Dong SM,Kim BR,et al.Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells［J］.Apoptosis,2012,17(9):989-997.
[13]Wang Wei,Liu Xingyan,Cheng Xiaoguang,et al.Mitoxantrone hydorchloride（MTX） induces apoptosis of human nasopharyngeal carcinoma cell line CNE-2 via PI3K pathway［J］.Modern Oncology,2015,23(2):153-156.［王炜，刘星言，程小广，等.盐酸米托蒽醌通过PI3K途径诱导人鼻咽癌CNE-2细胞凋亡［J］.现代肿瘤医学,2015,23(2):153-156.］
[14] Wang YY,Pathology DO,Hospital SC.The expression of Ezrin in gastric carcinoma and lymph node metastasis focus and its significance［J］.J Qiqihar University of Med,2015,3:11-13.
[15]Zhang Wei,Liu Yuanyuan,Xu Donglai,et al.E-cadherin and Ezrin expression in colorectal carcinoma and its significance［J］.China Laboratory Diagnos,2010,14（4):565-567.［张伟，刘媛媛，徐东来，等.E-cadherin和Ezrin在大肠癌组织中的表达及意义［J］.中国实验诊断学，2010，14(4)：565-567.］
[16]Sun Jing,Tian Jun,Wu Guiqing,et al.Ezrin and Fascin expression in laryngeal squamous cell carcinoma and its significance［J］.Modern Med Health,2012,28（3):339-340.［孙静,田军,吴桂卿,等.Ezrin和Fascin在喉鳞状细胞癌组织中的表达及意义［J］.现代医药卫生,2012,28(3):339-340.］
[17] Leiphrakpam PD,Rajput A,Mathiesen M,et al.Ezrin expression and cell survival regulation in colorectal cancer［J］.Cell Signal，2014,26(5):868-879.
[18]Guo Lin,Wang Qiang.PI3K/Akt/mTOR signal transduction pathway and tumor invasion and metastasis development［J］.Modern Oncology,2009,17（8):1585-1588.［郭琳,王强.PI3K/Akt/mTOR信号传导通路与恶性肿瘤浸润和转移的研究进展［J］.现代肿瘤医学,2009,17(8):1585-1588.］
[19]Wang Y,Lin Z,Sun L.Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma ［J］.Br J Cancer,2014,110(3):695-705.